LAMSight
LAMSight is a community dedicated to fast-tracking LAM research. LAM stands for Lymphangioleiomyomatosis, a rare, fatal, multi-system disease affecting women in their childbearing years. The goal of the community is to facilitate interaction between researchers and LAM patients, and to provide a single common community for LAM patients.
The community is built by Ian Eslick, a QS Bay Area presenter, and PhD candidate at the New Media Medicine group at MIT's Media Lab.